Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000212304 | SCV000210855 | benign | not specified | 2014-07-01 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000160349 | SCV000214401 | likely benign | Hereditary cancer-predisposing syndrome | 2014-07-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001085191 | SCV000259993 | likely benign | Familial cancer of breast; Fanconi anemia complementation group J | 2025-01-20 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000410903 | SCV000489865 | likely benign | Fanconi anemia complementation group J | 2016-08-29 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000411984 | SCV000489866 | likely benign | Ovarian neoplasm | 2016-08-29 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000160349 | SCV000684308 | likely benign | Hereditary cancer-predisposing syndrome | 2016-04-22 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000759717 | SCV000889227 | likely benign | not provided | 2018-08-20 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000160349 | SCV002529240 | likely benign | Hereditary cancer-predisposing syndrome | 2021-09-16 | criteria provided, single submitter | curation | |
Myriad Genetics, |
RCV003315956 | SCV004019351 | benign | Familial cancer of breast | 2023-02-28 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Breakthrough Genomics, |
RCV000759717 | SCV005211181 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000212304 | SCV005727226 | likely benign | not specified | 2024-11-04 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004535040 | SCV004748874 | likely benign | BRIP1-related disorder | 2019-06-14 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |